
Abbott India Ltd. is Rated Sell
2026-01-24 10:10:39Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 12 January 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2026-01-14 08:02:52Abbott India Ltd. has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical signals suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2026-01-06 08:28:30Abbott India Ltd. has witnessed a nuanced shift in its technical momentum as of early January 2026, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 0.37%, the stock’s technical landscape reveals a complex interplay of bullish and bearish signals across weekly and monthly timeframes, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.
Read full news article
Abbott India Ltd. is Rated Hold
2026-01-04 10:10:27Abbott India Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Abbott India Ltd. Technical Momentum Shifts Amid Bearish Signals
2026-01-02 08:12:08Abbott India Ltd. has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some bullish nuances. The stock’s recent downgrade from a Sell to a Hold rating reflects this evolving landscape, as investors weigh the implications of weakening price momentum against the broader pharmaceutical sector backdrop.
Read full news article
Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2026-01-01 08:08:04Abbott India Ltd. has witnessed a notable shift in its technical momentum as it transitions from a bearish to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.42%, the stock’s mixed signals across weekly and monthly charts suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Abbott India Ltd. Technical Momentum Shifts Amid Mixed Market Signals
2025-12-31 08:10:32Abbott India Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite this, certain weekly indicators such as the Relative Strength Index (RSI) suggest pockets of bullishness, creating a complex technical landscape for investors to navigate as the stock trades near ₹28,595.
Read full news article
Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2025-12-30 08:15:29Abbott India Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum as of late December 2025. While the stock’s overall trend has moved from bearish to mildly bearish, a closer examination of key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveals a complex interplay of signals that investors should carefully consider.
Read full news article
Abbott India Ltd. is Rated Sell
2025-12-24 20:23:35Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 02 Dec 2025. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 24 December 2025, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Abbott India Ltd. has declared 4750% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
No Rights history available






